Top Ambulatory Healthcare Service Companies

Global Ambulatory Healthcare Service Market size was valued at USD 4.55 Billion in 2024 and is poised to grow from USD 4.82 Billion in 2025 to USD 7.63 Billion by 2033, growing at a CAGR of 5.9% during the forecast period (2026–2033).

The global market of ambulatory healthcare services is undergoing rapid growth in response to demand for outpatient service, advancements in technology, and cost-friendly treatments. Industry leaders are adopting innovative approaches to providing services and to increasing market positions. For instance, HCA Healthcare and Tenet Healthcare Corporation are expanding networks of outpatient clinics through acquisition and partnerships in pursuit of increasing access and reducing the cost of inpatient care. Fresenius Medical Care is determined to integrate telehealth into dialysis treatment, enhance patient monitoring, and reduce the length of stay in hospitals. DaVita Inc. also makes investments in home-based treatment models, demonstrating a trend shift towards patient-centric services. These strategic initiatives represent a competitive landscape which is focused on expanding access and integrating advanced Technologies but delivering cost-effective and patient-centric care. 'Aspen Healthcare Ltd. (UK)', 'Ayala Corp. (Philippines)', 'DaVita Inc. (US)', 'EBOS Group Ltd. (New Zealand)', 'Fresenius SE and Co. KGaA (Germany)', 'HCA Healthcare Inc. (US)', 'Medical Facilities Corp. (Canada)', 'NueHealth (US)', 'SCA Health (US)', 'Sonic Healthcare Ltd. (Australia)', 'Surgery Partners Inc. (US)', 'Tenet Healthcare Corp. (US)', 'Healthway Medical Group (Singapore)', 'Rite Aid Corporation (US)', 'Mednax, Inc. (US)', 'CVS Health Corporation (US)', 'Kaiser Permanente (US)'

As medical costs increase, both patients and providers are seeking lower-cost care. Ambulatory health services offer a cost-effective option to hospitalization since diagnosis, treatment, and recovery can be accomplished without the need for an overnight hospital stay. This is particularly appealing for minor procedures, diagnostics, and chronic disease management. Payers and insurance carriers are also incentivizing outpatient care to reduce overall healthcare costs. Affordability and cost-effectiveness of ambulatory care facilities are leading them to become widely utilized throughout the globe, especially in healthcare regions where the containment of cost is important.

North America has the largest market share in the global ambulatory healthcare service market and the region contributes approximately 42% of the world revenue, led by its sophisticated healthcare infrastructure, extensive use of outpatient services, and favorable government policies. For instance, the U.S. Department of Health and Human Services invested around $60 million in 125 HRSA-funded community health centers during the year 2025 with a focus to increase ambulatory care services availability. Furthermore, the North America has a very large number of ambulatory care facilities, approximately 742,000 as of Q2 2024, also further adds to North America's market leading position.